Deutsche Bank’s Fortress Biotech FBIO Stock Holding History

Deutsche Bank’s Portfolio FBIO Stock Details FBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-2,793	Closed	-$57K	–	4187
2022 Q1	$57K	Sell	2,793 -319	-10%	-$8.73K	﹤0.01%	3792
2021 Q4	$117K	Buy	3,112 +151	+5%	+$6.74K	﹤0.01%	3639
2021 Q3	$143K	Sell	2,961 -88	-3%	-$4.3K	﹤0.01%	3729
2021 Q2	$163K	Sell	3,049 -158	-5%	-$9.53K	﹤0.01%	3902
2021 Q1	$169K	Buy	3,207 +12	+0.4%	+$677	﹤0.01%	3722
2020 Q4	$152K	Sell	3,195 -2,442	-43%	-$106K	﹤0.01%	3620
2020 Q3	$341K	Buy	5,637 +3,640	+182%	+$185K	﹤0.01%	2878
2020 Q2	$81K	Buy	+1,997	New	+$74.2K	﹤0.01%	3556
2020 Q1	–	Sell	-819	Closed	-$31K	–	4471
2019 Q4	$31K	Sell	819 -1,610	-66%	-$41.3K	﹤0.01%	4146
2019 Q3	$51K	Buy	2,429 +1,800	+286%	+$42.3K	﹤0.01%	3919
2019 Q2	$13K	Sell	629 -2,459	-80%	-$63.2K	﹤0.01%	4906
2019 Q1	$81K	Sell	3,088 -10,745	-78%	-$282K	﹤0.01%	4377
2018 Q4	$177K	Sell	13,833 -16,266	-54%	-$272K	﹤0.01%	3940
2018 Q3	$722K	Buy	30,099 +17,967	+148%	+$575K	﹤0.01%	3551
2018 Q2	$542K	Buy	12,132 +3,729	+44%	+$210K	﹤0.01%	3805
2018 Q1	$572K	Buy	8,403 +322	+4%	+$20.4K	﹤0.01%	3630
2017 Q4	$482K	Sell	8,081 -522	-6%	-$30.7K	﹤0.01%	3618
2017 Q3	$569K	Buy	8,603 +5,285	+159%	+$356K	﹤0.01%	3356
2017 Q2	$235K	Buy	3,318 +2,765	+500%	+$163K	﹤0.01%	3840
2017 Q1	$30K	Sell	553 -862	-61%	-$38.6K	﹤0.01%	4378
2016 Q4	$57K	Buy	1,415 +1,041	+278%	+$38.9K	﹤0.01%	4316
2016 Q3	$16K	Sell	374 -3,181	-89%	-$135K	﹤0.01%	4587
2016 Q2	$143K	Sell	3,555 -681	-16%	-$31.7K	﹤0.01%	3921
2016 Q1	$196K	Buy	4,236 +782	+23%	+$33K	﹤0.01%	3668
2015 Q4	$143K	Sell	3,454 -33	-0.9%	-$1.38K	﹤0.01%	3884
2015 Q3	$135K	Sell	3,487 -8,118	-70%	-$379K	﹤0.01%	3970
2015 Q2	$584K	Buy	11,605 +8,405	+263%	+$431K	﹤0.01%	3305
2015 Q1	$184K	Buy	3,200 +1,000	+45%	+$41.7K	﹤0.01%	3821
2014 Q4	$80K	Sell	2,200 -2,667	-55%	-$78.5K	﹤0.01%	4857
2014 Q3	$153K	Sell	4,867 -2,881	-37%	-$76.5K	﹤0.01%	4242
2014 Q2	$199K	Buy	7,748 +486	+7%	+$12.8K	﹤0.01%	4127
2014 Q1	$214K	Buy	7,262 +6,917	+2,005%	+$270K	﹤0.01%	3857
2013 Q4	$13K	Sell	345 -3,513	-91%	-$136K	﹤0.01%	4835
2013 Q3	$405K	Buy	3,858 +1,620	+72%	+$199K	﹤0.01%	3664
2013 Q2	$286K	Buy	+2,238	New	+$330K	﹤0.01%	3569

Other funds holding FBIO

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OMC

Oasis Management Company Grand Cayman, Cayman Islands $1.72B AUM 32.1% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

SAM

Shikiar Asset Management New York $347M AUM 23.44% 1-Year Est. Return

CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Deutsche Bank's FBIO Position: Q2 2022 in Review

Deutsche Bank sold out of Fortress Biotech (FBIO) in Q2 2022, closing a stake of 2,793 shares — an estimated $57K sold.

Deutsche Bank first reported a position in FBIO in Q2 2013 and held it in 35 quarters. The position peaked at $722K in Q3 2018. 66 funds tracked by Wall St. Rank hold FBIO as of Q2 2022.

Deutsche Bank reported no remaining Fortress Biotech position as of Q2 2022 after selling out during the quarter.
Deutsche Bank sold 2,793 Fortress Biotech shares in Q2 2022, an estimated $57K.
Deutsche Bank first reported a position in Fortress Biotech in Q2 2013 and held it in 35 quarters.
Deutsche Bank's Fortress Biotech position peaked at $722K in Q3 2018.
66 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2022.

Based on Deutsche Bank's 13F filing for Q2 2022, filed 11 Aug 2022.